S.-W. Park et al. / Tetrahedron: Asymmetry 10 (1999) 1903–1911
1909
4.6. (S)-8-Diphenylphosphino-2-(4-isopropyl-2-oxazolin-2-yl)quinoline 4a
A mixture of NiCl2(dppe) (410 mg, 0.77 mmol) and diphenylphosphine (0.40 mL, 2.3 mmol) in DMF
was heated at 100°C for 30 min, and then it was cooled to 80°C. To this mixture was added a solution
of oxazoline 9a (3.0 g, 7.72 mmol) and 1,4-diazabicyclo[2.2.2]octane (1.73 g, 15.4 mmol) in DMF (10
mL) through a cannula. Additional diphenylphosphine (1.2 mL, 6.7 mmol) was added, and the resulting
mixture was stirred for 8 h at 80°C. After cooling the reaction mixture to room temperature, most of the
DMF was removed by vacuum distillation. The residue was diluted with dichloromethane and washed
successively with 5% aqueous Na2S2O3, 10% aqueous citric acid solution, and brine. The organic phase
was dried and concentrated. The residue was purified by chromatography (50% ethyl ether in hexanes)
24
1
to give the product in 43% yield (1.49 g, 3.51 mmol). Mp 161.1°C; [α]D −94.4 (c 0.23, CHCl3); H
NMR (CDCl3, 300 MHz) δ 8.16 (s, 2H), 7.79 (d, 1H, J=8.1 Hz), 7.74 (t, 1H, J=7.4 Hz), 7.39–7.29
(m, 10H), 7.28–7.22 (m, 1H), 4.45 (dd, 1H, J=8.5, 1.2 Hz), 4.15 (t, 1H, J=8.5 Hz), 4.10–4.06 (m, 1H),
1.86–1.80 (m, 1H), 1.02 (d, 3H, J=6.7 Hz), 0.90 (d, 3H, J=6.7 Hz); 13C NMR (CDCl3, 75 MHz) δ 163.8,
146.5, 141.0, 140.8, 137.84, 137.81, 137.69, 137.67, 136.89, 136.87, 134.9, 134.8, 134.7, 134.6, 134.5,
128.9, 128.7, 128.6, 128.1, 121.6, 73.3, 71.2, 33.4, 19.5, 18.8; 31P NMR (CDCl3, 121 MHz) δ −12.59
(reference: H3PO4 in D2O). Anal. calcd for C27H25ON2P: C, 76.40; H, 5.94; N, 6.60. Found: C, 76.30;
H, 5.85; N, 6.54.
4.7. (S)-8-Diphenylphosphino-2-(4-phenyl-2-oxazolin-2-yl)quinoline 4b
Using a similar procedure, ligand 4b was prepared in 46% yield (830 mg, 1.85 mmol), starting from
oxazoline 9b (1.7 g, 4.02 mmol). Mp 84°C; [α]D24 −95.4 (c 2.49, CHCl3); 1H NMR (CDCl3, 300 MHz)
δ 8.54 (d, 1H, J=8.3 Hz), 8.33–8.23 (m, 2H), 7.86 (d, 1H, J=2.1 Hz), 7.52–7.13 (m, 16H), 5.43–5.36 (m,
1H), 3.83–3.68 (m, 2H); 13C NMR (CDCl3, 75 MHz) δ 164.2, 148.3, 147.6, 139.7, 139.0, 138.5, 135.2,
134.8, 134.7, 134.6, 134.4, 129.6, 129.4, 129.2, 129.12, 129.06, 129.01, 128.8, 128.7, 128.4, 127.2,
119.5, 54.4, 48.2; 31P NMR (CDCl3): δ −10.13 (reference: H3PO4 in D2O). Anal. calcd for C30H23ON2P:
C, 78.59; H, 5.06; N, 6.11. Found: C, 78.21; H, 4.72; N, 6.18.
4.8. (S)-8-Diphenylphosphino-2-(4-tert-butyl-2-oxazolin-2-yl)quinoline 4c
Using a similar procedure, ligand 4c was prepared in 47% yield (710 mg, 1.64 mmol), starting from
24
1
oxazoline 9c (1.4 g, 3.48 mmol). Mp 74–76°C; [α]D −93.5 (c 0.23, CHCl3); H NMR (CDCl3, 300
MHz) δ 8.16 (s, 2H), 7.79 (d, 1H, J=8.0 Hz), 7.45 (t, 1H, J=7.6 Hz), 7.39–7.26 (m, 10H), 7.23–7.19
(m, 1H), 4.39 (dd, 1H, J=10.3, 1.5 Hz), 4.24 (t, 1H, J=8.5 Hz), 4.05 (dd, 1H, J=10.3, 1.5 Hz), 0.93 (s,
9H); 13C NMR (CDCl3, 75 MHz) δ 163.7, 146.5, 140.9, 140.8, 137.8, 137.7, 136.8, 134.9, 134.8, 134.7,
134.6, 134.5, 128.9, 128.8, 128.7, 128.6, 128.1, 121.7, 76.7, 69.7, 34.4, 26.4; 31P NMR (CDCl3, 121
MHz) δ −12.86 (reference: H3PO4 in D2O). Anal. calcd for C28H27ON2P: C, 76.69; H, 6.21; N, 6.39.
Found: C, 76.39; H, 6.19; N, 6.50.
4.9. Representative procedure of the intermolecular cyclopropanation
A mixture of [RuCl2(p-cymene)]2 (24 mg, 0.04 mmol) and DPOQ 4a (34 mg, 0.08 mmol) in dry
dichloromethane (15 mL) was stirred for 1.5 h at 25°C. To this ruthenium complex was added styrene
(2.3 mL, 20 mmol) using a syringe, followed by a solution of ethyl diazoacetate (456 mg, 4.0 mmol) in
dichloromethane (5 mL) for 8 h using a syringe pump. The resulting mixture was stirred for a further 8